Werner Baumann, Bayer CEO (Sascha Steinbach/picture-alliance/dpa/AP Images)
May 15, 2023 04:13 PM EDTUpdated 04:57 PM
Pharma

Bay­er cuts four pro­grams amid a 's­low start' to the year

Nicole DeFeudis

Editor

Bay­er an­nounced a hand­ful of pipeline cuts in its quar­ter­ly earn­ings re­port last week, as CEO Wern­er Bau­mann re­vealed the quar­ter …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Will CRISPR mat­ter?

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

FDA says Ozem­pic, We­govy short­age is over

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times